The relatively small VAF of GNAS mutations in our tumor samples (on average 10.7%, ranging from 2.35% to 27.91%) match our observation that the tumors contain mostly fibroblasts (supportive cells) and endothelial cells, with only a small percentage of tumor cells. Here, GNAS is linked to neoplasm.